Amorim AMB, Piochi LF, Gaspar AT, Preto AJ, Rosário-Ferreira N, Moreira IS (2024) Advancing drug safety in drug development: bridging computational predictions for enhanced toxicity prediction. Chem Res Toxicol 37(6):827–849. https://doi.org/10.1021/acs.chemrestox.3c00352

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araújo AM, Carvalho F, Guedes de Pinho P, Carvalho M (2021) Toxicometabolomics: small molecules to answer big toxicological questions. Metabolites 11(10):692–722. https://doi.org/10.3390/metabo11100692

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohus E, Coen M, Keun HC, Ebbels TM, Beckonert O, Lindon JC, Holmes E, Noszál B, Nicholson JK (2008) Temporal metabonomic modeling of l-arginine-induced exocrine pancreatitis. J Proteome Res 7(10):4435–4445. https://doi.org/10.1021/pr800407j

Article  CAS  PubMed  Google Scholar 

Bollard ME, Contel NR, Ebbels TM, Smith L, Beckonert O, Cantor GH, Lehman-McKeeman L, Holmes EC, Lindon JC, Nicholson JK, Keun HC (2010) NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. J Proteome Res 9(1):59–69. https://doi.org/10.1021/pr900200v

Article  CAS  PubMed  Google Scholar 

Cantor GH, Beckonert O, Bollard ME, Keun HC, Ebbels TM, Antti H, Wijsman JA, Bible RH, Breau AP, Cockerell GL, Holmes E, Lindon JC, Nicholson JK (2013) Integrated histopathological and urinary metabonomic investigation of the pathogenesis of microcystin-LR toxicosis. Vet Pathol 50(1):159–171. https://doi.org/10.1177/0300985812443839

Article  CAS  PubMed  Google Scholar 

Ebbels TMD, Keun HC, Beckonert OP, Bollard ME, Lindon JC, Holmes E, Nicholson JK (2007) Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J Proteome Res 6(11):4407–4422. https://doi.org/10.1021/pr0703021

Article  CAS  PubMed  Google Scholar 

Ericsson AC, Franklin CL (2021) The gut microbiome of laboratory mice: considerations and best practices for translational research. Mamm Genome 32(4):239–250. https://doi.org/10.1007/s00335-021-09863-7

Article  PubMed  PubMed Central  Google Scholar 

Garrod S, Bollard ME, Nicholls AW, Connor SC, Connelly J, Nicholson JK, Holmes E (2005) Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem Res Toxicol 18(2):115–122

Article  CAS  PubMed  Google Scholar 

Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet JM, Loukaci A, Thomas C (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187(3):137–146. https://doi.org/10.1016/s0041-008x(02)00079-0

Article  CAS  PubMed  Google Scholar 

Lindon JC, Keun HC, Ebbels TM, Pearce JM, Holmes E, Nicholson JK (2005) The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6(7):691–699. https://doi.org/10.2217/14622416.6.7.691

Article  CAS  PubMed  Google Scholar 

Molon-Noblot S, Boussiquet-Leroux C, Owen RA, Irisarri E, Durand-Cavagna G, Peter CP, Duprat P (1992) Rat urinary bladder hyperplasia induced by oral administration of carbonic anhydrase inhibitors. Toxicol Pathol 20(1):93–102. https://doi.org/10.1177/019262339202000111

Article  CAS  PubMed  Google Scholar 

Nicholson JK et al (1989) Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol Pharmacol 36(3):398–404

Article  CAS  PubMed  Google Scholar 

Nicholson et al (2002). https://doi.org/10.1038/nrd728

Olesti E, González-Ruiz V, Wilks MF, Boccard J, Rudaz S (2021) Approaches in metabolomics for regulatory toxicology applications. Analyst 146(6):1820–1834. https://doi.org/10.1039/D0AN02212H

Article  CAS  PubMed  Google Scholar 

Owen RA, Durand-Cavagna G, Molon-Noblot S, Boussiquet-Leroux C, Berry PH, Tonkonoh N, Peter CP, Gordon LR (1993) Renal papillary cytoplasmic granularity and potassium depletion induced by carbonic anhydrase inhibitors in rats. Toxicol Pathol 21(5):449–455. https://doi.org/10.1177/019262339302100504

Article  CAS  PubMed  Google Scholar 

Radi ZA (2019) Kidney pathophysiology, toxicology, and drug-induced injury in drug development. Int J Toxicol 38(3):215–227. https://doi.org/10.1177/1091581819831701

Article  CAS  PubMed  Google Scholar 

Ramaiah SK (2007) A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol 45(9):1551–1557. https://doi.org/10.1016/j.fct.2007.06.007

Article  CAS  PubMed  Google Scholar 

Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85(2):809–822. https://doi.org/10.1093/toxsci/kfi102

Article  CAS  PubMed  Google Scholar 

Robertson DG, Watkins PB, Reily MD (2011) Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci 120(S1):S146–S170. https://doi.org/10.1093/toxsci/kfq358

Article  CAS  PubMed  Google Scholar 

Robosky LC, Wells DF, Egnash LA, Manning ML, Reily MD, Robertson DG (2005) Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats. Toxicol Sci 87(1):277–284. https://doi.org/10.1093/toxsci/kfi214

Article  CAS  PubMed  Google Scholar 

Sanins et al (1992). https://doi.org/10.1007/BF01970674

Shockcor JP, Holmes E (2002) Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2(1):35–51. https://doi.org/10.2174/1568026023394498

Article  CAS  PubMed  Google Scholar 

Silverman W, Locovei S, Dahl G (2008) Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol 295(3):C761–C767. https://doi.org/10.1152/ajpcell.00227.2008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith JR, Bolton ER, Dwinell MR (2019) The Rat: A Model Used in Biomedical Research. In: Hayman G, Smith J, Dwinell M, Shimoyama M (eds) Rat Genomics. Methods in molecular biology, vol 2018. Humana, New York, pp 1–41

Stark C, Steger-Hartmann T (2015) Nonclinical Safety and Toxicology. In: Nielsch U, Fuhrmann U, Jaroch S (eds) New Approaches to Drug Discovery, vol 232. Springer, Cham, pp 261–283

Chapter  Google Scholar 

Tosca EM, Bartolucci R, Magni P, Poggesi I (2021) Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity. Expert Opin Drug Discov 16(11):1365–1390. https://doi.org/10.1080/17460441.2021.1931114

Article  CAS  PubMed  Google Scholar 

Tran TTV, Wibowo AS, Tayara H, Chong KT (2023) Artificial intelligence in drug toxicity prediction: recent advances, challenges, and future perspectives. J Chem Inf Model 63(9):2628–2643. https://doi.org/10.1021/acs.jcim.3c00200

Article  CAS  PubMed  Google Scholar 

Veselkov KA, Pahomov VI, Lindon JC, Volynkin VS, Crockford D, Osipenko GS, Davies DB, Barton RH, Bang JW, Holmes E, Nicholson JK (2010) A metabolic entropy approach for measurements of systemic metabolic disruptions in patho-physiological States. J Proteome Res 9(7):3537–3544. https://doi.org/10.1021/pr1000576

Article  CAS  PubMed  Google Scholar 

Walker PA, Ryder S, Lavado A, Dilworth C, Riley RJ (2020) The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Arch Toxicol 94:2559–2585. https://doi.org/10.1007/s00204-020-02763-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I, Giacomini KM, Krauss RM (2007) Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 6(11):904–916. https://doi.org/10.1038/nrd2423

Article